Dr. Angela P. Combs, DO

Dr. Combs practices at Skin and Cancer Associates in Sunrise, Florida.

Dr. Combs' NPI, 1336331453, was assigned on August 13, 2007. Dr. Combs graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2006. Dr. Combs holds Florida license OS10176.

Dr. Combs' primary practice is Skin and Cancer Associates, at 7800 W Oakland Park Blvd, Sunrise, FL 33351 in Broward County. The practice phone is (954) 473-6750.

Dr. Combs' primary practice is Skin and Cancer Associates in Sunrise, Florida. The medical group on file is Skin and Cancer Associates. Dmand AI also links Dr. Combs to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Combs practices. Vendor and product names are available with a free account.

Dermatology is Dr. Combs' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Combs is board certified in dermatology by the AOA Board of Dermatology. Dr. Combs is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and itchy rashes among the conditions Dr. Combs treats.

CMS data shows 2,202 Medicare services from Dr. Combs across 12 procedure codes in 2024, for 575 Medicare patients. Medicare paid $96,340 for them. Every service was in an office.

CMS counts 575 Medicare patients who saw Dr. Combs in 2024. The largest group is 65 to 74, with 283 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Combs' median patient age at 70, with 59% women.

In 2024, Dr. Combs wrote 2,609 Medicare Part D claims for 941 patients. 92% of them were for generic drugs. CMS names the drug for 2,439 of them, across 28 drugs with 11 or more claims each, at $534,527 in total drug cost. In 2023, CMS named 1,716 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Combs for performance year 2024, reported individually. Dr. Combs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,046 procedures of removal of skin lesions by Dr. Combs, more than 93% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Combs, published from 2019 to 2020. Dr. Combs' most frequent co-authors are Maher Albitar, Gregory Bartos, DO and Marcus Brian Goodman, DO.

CMS Open Payments shows 300 general payments to Dr. Combs from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $1,674.

Dmand AI lists 2 awards for Dr. Combs, most recently CMS Stage 1 EHR in 2013.

Dr. Combs graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2006. Dr. Combs is a member of AAD and AOA.

Dr. Combs is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.